Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience-Reference-Cited by-同舟云学术

Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience

Published:2004-11 Issue:11 Volume:15 Page:1645-1653
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Lorent N.,De Leyn P.,Lievens Y.,Verbeken E.,Nackaerts K.,Dooms C.,Van Raemdonck D.,Anrys B.,Vansteenkiste J.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/15/11/1645/536966/mdh435.pdf

Reference36 articles.

1. The role of surgery in N2 lung cancer;Martini;Surg Clin North Am,1987

2. N2 (clinical) non-small cell carcinoma of the lung: prospective trials of radiation therapy with total doses 60 GY by the radiation therapy oncology group;Cox;Int J Radiat Oncol Biol Phys,1991

3. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung;Pearson;J Thorac Cardiovasc Surg,1982

4. Survival and prognostic factors in resected N2 non-small cell lung cancer: A study of 140 cases;Vansteenkiste;The Leuven Lung Cancer Group. Ann Thorac Surg,1997

5. Present status of induction treatment for N2 non-small cell lung cancer: A review;Vansteenkiste;Eur J Cardiothorac Surg,1998

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment Options;Current Oncology;2023-03-07

2. Neoadjuvant Therapy and Factors Influencing Survival in Locally Advanced Non-Small Cell Lung Cancer;Cureus;2023-01-05

3. Survival Analysis of Surgically Resected ypN2 Lung Cancer after Neoadjuvant Therapy;The Thoracic and Cardiovascular Surgeon;2022-03-02

4. A PET/CT nomogram incorporating SUVmax and CT radiomics for preoperative nodal staging in non-small cell lung cancer;European Radiology;2021-02-09

5. Heterogeneity of stage IIIA non-small cell lung cancer—different tumours, different nodal status, different treatment, different prognosis: a narrative review;Current Challenges in Thoracic Surgery;2021-01